(Q48306948)

10 February 2018

title

Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia (English)

1 reference

10 February 2018

author name string

Lizu Xiao

1

1 reference

10 February 2018

Sean Mackey

2

1 reference

10 February 2018

Hui Hui

3

1 reference

10 February 2018

Donglin Xong

4

1 reference

10 February 2018

Qian Zhang

5

1 reference

10 February 2018

Deren Zhang

6

1 reference

10 February 2018

publication date

1 December 2010

1 reference

10 February 2018

published in

Pain Medicine

1 reference

10 February 2018

volume

11

1 reference

10 February 2018

issue

12

1 reference

10 February 2018

page(s)

1827-1833

1 reference

10 February 2018

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

EFNS guidelines on pharmacological treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Pharmacologic management of neuropathic pain: evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Clinical value of botulinum toxin in neurological indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Treatment of spasticity with botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Subcutaneous administration of botulinum toxin A reduces formalin-induced pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

A focused review on the use of botulinum toxins for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Sympathetic block with botulinum toxin to treat complex regional pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Botulinum toxin and intractable trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Botulinum neurotoxins: mechanism of action and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

Effects of antiepileptic drugs on attention as assessed by a five-choice serial reaction time task in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2010.01003.X

10.1111/J.1526-4637.2010.01003.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018